CompletedNCT00500201

A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.

Medication studyAges 18–55United KingdomSchizophrenia

The study in practice

Understand this study

This study was for healthy volunteers. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Study clarity

Study start dateStarted: May 24, 2007

Recruitment status: Completed
Enrollment listed in the registry: 18
Sponsor: GlaxoSmithKline
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 1
Locations: United Kingdom
Age range: From 18 Years to 55 Years
Official registry ID: NCT00500201
Official title: Show the full official title
A Single Blind, Double Dummy, Placebo Controlled, Randomized, 2 Period Crossover Study to Assess the Relative Bioavailability of a 120mg Tablet Compared to Two 60 mg SB-773812 Tablets in Healthy Volunteers

Completed

London

FAQ

Who is behind this study?

The study sponsor is GlaxoSmithKline.

Did this study involve medication?

Yes. The study involved medication, including SB- 773812 60 mg, SB- 773812 120 mg and Placebo.

Who was this study for?

This study was for healthy volunteers. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Explore other studies

Explore HopeStage studies by mental health topic and refine the results to suit your situation.